macrophage tropism, cytopathogenicity, CD4 antigen modulation, and susceptibility to serum neutralization. The results of these studies indicate that the envelope region contains the major determinants of these viral features. Further studies with sequence exchanges within this region should help identify specific domains that contribute to HIV pathogenesis.
The genomes of different human immunodeficiency virus type 1 (HIV-1) strains display a high degree of sequence variations (2, 5, 24, 49, 55, 63) . Besides this well-recognized genetic heterogeneity, HIV-1 isolates vary in their host range tropism (8, 10, 16, 34) , kinetics of replication (4, 11, 32, 59) , and susceptibility to serum neutralization (9) . Furthermore, differences in their ability to down modulate the CD4 receptor molecule and to induce cytopathology in infected cells have been observed (12, 17, 25, 58, 59) . Some of these biologic properties have correlated with pathogenicity of the virus (11, 60) . Results from our previous studies showed that HIV-1 isolates recovered from patients with advanced disease are more cytopathic, replicate with faster kinetics and to higher titers, and display a wider host range than isolates obtained from the same individuals when they were healthy. The later isolates infected several established T-cell lines (e.g., HUT-78 and Jurkat), some B-cell lines, and primary peripheral blood macrophages (11) . In addition, we have found that isolates recovered from the central nervous system display biologic and serologic properties which distinguish them from viruses recovered from peripheral blood (12) . The HIV-1 genes that control these different biologic and replicative abilities of the virus, and hence influence pathogenesis, are still largely undefined. An understanding of the functional role of each viral gene in the replicative cycle and of the mechanism by which each gene exerts its effect are important steps towards the development of antiviral drugs and a vaccine.
In this report, structure and function studies were performed to begin mapping the HIV-1 genes that control different viral properties. Two HIV-1 isolates showing differences in T-cell and macrophage tropism, cytopathogenicity, CD4 receptor downmodulation, and sensitivity to serum neutralization have been molecularly cloned. Recombinant DNAs were generated by reciprocal exchange of genetic materials between the two isolates, and the biologic and serologic properties of the recombinant viruses obtained by * Corresponding author. recombinant DNA transfection were determined. The results indicate that the envelope region contains the major determinants of the viral properties examined.
MATERIALS AND METHODS

Cells. HUT-78 and Jurkat T-cell lines (obtained from the
American Type Culture Collection) were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated (56°C, 30 min) fetal calf serum, 2 mM glutamine, and 1% antibiotics (100 U of penicillin per ml and 100 ,ug of streptomycin per ml) (16) . Phytohemagglutinin (3 ,ug/ml)-stimulated peripheral blood mononuclear cells (PMC) were maintained in the same medium, which contained interleukin-2 (5%) (Electronucleonics, Silver Spring, Md.). Purified CD4+ cells were prepared by the panning procedure with Leu 3a monoclonal antibodies (Becton Dickinson, Mountain View, Calif.) as described previously (65) and maintained in the same medium. Primary monocytes were obtained from FicollHypaque-gradient-purified PMC by the plastic adherent technique (12, 21) . In order to allow for differentiation into macrophages, the adherent cells were cultured for 10 to 12 days in RPMI 1640 medium supplemented with 10% fetal calf serum, 5% heat-inactivated human serum, and 1% antibiotics before infection with HIV-1 (11). Human rhabdomyosarcoma (RD-4) cells were obtained from the American Type Culture Collection and maintained as monolayer cultures in Dulbecco modified Eagle medium supplemented with 10% fetal calf serum and antibiotics (31) .
Virus. HIV-1SF2, our prototype peripheral blood HIV-1 isolate (formerly called acquired immune deficiency syndrome-associated retrovirus, ARV-2), was recovered by cocultivation of mitogen-stimulated PMC from seronegative donors with PMC from a patient with oral candidiasis (33) .
HIV-lSF162 was obtained by cocultivation of PMC from seronegative donors with cerebrospinal cord fluid of a HIV-1-seropositive patient with toxoplasmosis (12) . Both isolates were grown to high titers in PMC (i.e., reaching levels of reverse transcriptase [RT] activity of >106 cpm/ml) and then frozen in 1 ml aliquots at -70°C for future studies. had been molecularly cloned and sequenced (31, 38, 50 HIV-1 infection. T-cell lines, purified CD4+ cells, or peripheral blood macrophages were treated with Polybrene (2 ,ug/ml) for 30 min at 37°C and exposed to 1 ml of virus-containing fluids (RT activity, 106 cpm/ml or 100 50% tissue culture infectious doses) for 1 h at 37°C. Cells were then washed three times and maintained in culture medium. Culture supernatants of these infected cells were harvested at 3-to 4-day intervals and assayed for RT activity as described previously (27) . The presence of HIV-1 viral antigens in infected cells was further confirmed by immunoblot analysis (45) (38) . The orientation of gag and env genes was identified by hybridization to HIV-1 gag-and env-specific probes. For DNA sequencing, portions of the 3' subclone DNA of HIV-1SF162 were subcloned into single-stranded bacteriophage M13 vectors and sequenced by the dideoxynucleotide-chain termination method (42, 51) . Homologous regions of the viral genes between HIV-1SF2 and HIV-1SF162 were identified by using the GENALIGN computer program (40) .
Generation of recombinant DNA and viruses. A methodology similar to the one used in the studies of integration and expression of Rous sarcoma virus (37) and described in our previous study (66) (12) . and HIV-1SF162 is presented in Fig. 2 . The data show that differences were clustered primarily within the five hypervariable regions of gp120 (43) , including the RP135 loop region (46, 48) (amino acids 298 to 412, according to the coding sequence of HIV-lSF162). The 22 cysteine residues, the CD4-binding domain (amino acids 403 to 446) (15, 30) , and the gpl2O/gp4l cleavage site (amino acid 503) (6, 23) are highly conserved in the two isolates. Amino acid differences were observed in the putative gp4l fusion domain (amino acids 503 to 530) (7, 20, 22) . These are the absence of a glycine in HIV-lSFl62 and the substitution of a leucine and arginine in that strain for isoleucine and valine residues, respectively, in HIV-lSF2. revealed minor restriction site differences (Fig. 3) . For example, the absence of a HindlIl and SspI site and the addition of a PstI site were found in HIV-lSF162. Furthermore, the restriction enzyme patterns of Scal and BgII reveal some differences. A common XhoI site was present in the nef region of each viral genome; therefore, a double digestion of the 3' portion of the genome with EcoRI and XhoI could be used to release a 3.2-kb fragment containing the env region plus 36 or 38 amino acids from the N terminus of nef (Fig. 3) (Table 3) . Furthermore, the parental viruses, Rl and R2, generated by this method displayed properties identical to those of viruses recovered by transfection with the full-length viral DNA (Table 1) . Structural and genomic analyses of recombinant viruses. Immunoblot and Southern blot analyses of the recombinant viruses obtained were performed to confirm their genomic and protein structures. Immunoblot analysis of HIV-lSF162-and HIV-lsF2-infected cells showed that the major external envelope glycoprotein (gpl20), the p55 precursor, and p17 gag proteins of the two viruses differ in molecular size (Fig.  SA) . The size differences in these viral proteins, therefore, served as markers for the presence of the respective 5' gag and 3' env regions. For example, the R5 virus was shown to contain the envelope proteins of HIV-lSF162 and gag proteins of HIV-1SF2; the R6 virus contains the envelope proteins of HIV-IsF2 and gag proteins of HIV-lSF162 (Fig.   SA) . Southern blot analyses also demonstrated the characteristic restriction endonuclease fragment hybridization patterns expected for each recombinant virus upon digestion of their genomic DNAs with ScaI-XhoI. Results are shown for recombinant viruses R5 and R6 (Fig. SB) . A 2.2-and a 1.49-kb ScaI-XhoI fragment, both present in recombinant virus R5, are characteristic fragments in the env region of HIV-1SF162 (Fig. 3 and SB) logic studies with the recombinant viruses generated are summarized in Table 3 (Table 3) . Therefore, in agreement with our other studies in which recombinant viruses between HIV-lSF2 and HIV-lSF33 were used (66) , the cytopathogenicity of HIV-1 was found associated with a 3.2-kb EcoRI-XhoI fragment of the 3' region of the genome. Moreover, the other properties examined in the present studies, such as T-cell and macrophage tropism, the ability to down modulate the CD4 receptor molecule, and sensitivity to serum neutralization, also segregated with this region (Table 3) . (50, 51) . Homologous regions of the viral genes were identified by using the GENALIGN computer program (40) .
erties of the HIV-1 strains examined. This region identified has coding sequences for the env, tat, rev, and vpu genes and 36 amino acids from the N terminus of nef (Fig. 3) . The tat and rev genes are positive regulators of HIV-1 replication (3, 18, 53, 54, 64) , and the vpu gene has been shown to facilitate efficient production of mature infectious virions (13, 57, 61 (38) . For HIV-lSFl62, DNA from a recombinant lambda clone (clone 40-1) containing the full-length genome was prepared and digested with EcoRI. The 4.5-kb EcoRI fragment containing the env region, as identified by hybridization to a radioactive env-specific probe, was subcloned into pUC19. Restriction mapping of the 3' subcloned viral DNA was performed as described previously (39) . Differences in the restriction enzyme maps of both clones are indicated by arrows pointing to addition of restriction sites and by dotted bars denoting absence of restriction sites. Boldface letters denote enzymes (EcoRI and XhoI) used to generate fragments in the construction of env recombinant plasmids. 52, 56) and recently with recombinant viruses (66) . Moreover, a previous study with chimeric viruses also indicated that host range tropism is in part determined at the level of the viral envelope (19) . This study used hybrid genomes in which the envelope region of six viral clones obtained within the same individual were separately substituted into a biologically active prototype HIV-1 genome. Thus, this approach measures only the effect of the env gene. However, the chimeric viruses obtained replicated with different kinetics (19) , and this raises the possibility that alterations in other regions of the HIV-1 genome (e.g., regulatory elements) might have contributed to the biological differences observed. The finding that recombinant viruses generated in our studies replicated with similar kinetics and titers (Tables  1 and 3) (Fig. 2) , including the amino acids implicated in tropism for the monocytic U937 cells (14) .
Furthermore, HIV-lSF162 is biologically active upon transfection into HUT-78 cells (data not shown). These findings agree with previous studies showing that the binding to T-cell lines is comparable between HIV-1 isolates that differ in their ability to productively infect these target cells (16) and suggest that a postbinding entry process, perhaps fusion, is responsible for the difference in host range tropisms observed with HIV-lSF2 and HIV-lSF162. Amino acid differences were observed in the putative gp4l fusion domain of HIV-lSF162 and HIV-lSF2 (Fig. 2) (46) (47) (48) . Whether these changes are responsible for macrophage tropism and other biologic properties of HIV-lSFl62 requires further study.
Finally, the variations present in the immunodominant RP135 loop region (Fig. 2 , amino acids 298 to 412) (46, 48) are likely to be responsible for the difference in neutralization patterns of the two isolates. Fine structure mapping of the envelope region of HIV-1 with additional recombinant viruses, together with site-directed mutagenesis studies, should allow the identification of the specific domains within the env region that control these host range and cytopathic and antigenic properties of HIV-1.
